On January 31, 2019, the Department of Health and Human Services (HHS) released a notice of proposed rulemaking (the Proposed Rule) as part of ongoing administration drug pricing reform efforts. The Proposed Rule would modify a regulatory provision that had previously protected certain pharmaceutical manufacturer rebates from criminal prosecution and financial penalties under the federal
Kate McDonald focuses her practice on transactional and regulatory counseling for clients in the health care industry, with particular focus on federal and state health care government programs and the intersection between health care payors and providers. Kate regularly advises health insurers, health maintenance organizations (HMOs), health care government contractors, health care providers and other clients on compliance with health care laws and regulations, particularly in connection with Medicare Advantage, Medicare Part D, Medicaid managed care, the Affordable Care Act, state insurance laws, and state licensure and professional practice regulations. Read Kate McDonald's full bio.